Table 2:
Control n=31 | Treatment n=34 | ASMD | |
---|---|---|---|
Pain | |||
PACU | 3.6 (3.2) | 2.9 (2.9) | 0.24* |
POD1 | 5.4 (2.5) | 4.6 (2.1) | 0.32* |
POD2 | 4.6 (2.2) | 4.2 (2.2) | 0.2* |
POD7 | 4.2 (2.4) | 3.1 (2.3) | 0.46* |
POD30 | 1.5 (2) | 1.7 (1.6) | 0.15 |
Opioid consumption in OME (mg) | |||
PACU | 14.8 (11.2) | 13.7 (2.9) | 0.09 |
POD1 | 21.4 (14.7) | 18.4 (14.7) | 0.2* |
POD2 | 17.2 (15.4) | 11.6 (11.8) | 0.42* |
POD7 | 6.1 (7.5) | 6.9 (10.9) | 0.09 |
POD30 | 0.2 (0.9) | 0.4 (1.6) | 0.18 |
Acetaminophen (mg) | |||
PACU | 209 (344) | 196 (346) | 0.04 |
POD1 | 1508 (1331) | 1163 (874) | 0.31* |
POD2 | 1633 (1246) | 1088 (871) | 0.52* |
POD7 | 1269 (1395 | 664 (201) | 0.54* |
POD30 | 405 (732) | 514 (830) | 0.14 |
PONV Scores | |||
PACU | 0 (0.2) | 0 (0) | 0.26* |
POD1 | 1.1 (2.3) | 0.6 (1.3) | 0.25* |
POD2 | 0.8 (1.7) | 0.2 (0.8) | 0.44* |
POD7 | 0.3 (0.8) | 0.7 (1.4) | 0.36* |
POD30 | 0.2 (0.6) | 0.1 (0.4) | 0.24* |
PROMIS-Anxiety | |||
POD0 | 62.4 (4.1) | 61.2 (3.4) | 0.34* |
POD1 | 54.6 (6.2) | 52.4 (9.3) | 0.29 |
POD2 | 48.8 (8.2) | 50.9 (8.4) | 0.25* |
POD7 | 48.1 (8.3) | 47.8 (7.9) | 0.04 |
POD30 | 45.8 (7.8) | 47.0 (9.7) | 0.14 |
PROMIS-Depression | |||
POD0 | 50.8 (5.6) | 53.3 (7.2) | 0.4* |
POD1 | 47.7 (7.8) | 47.0 (9.1) | 0.15 |
POD2 | 43.5 (6.7) | 47.6 (8.6) | 0.55* |
POD7 | 44.5 (6.7) | 44.8 (7.7) | 0.04 |
POD30 | 43.6 (6.8) | 44.1 (9.7) | 0.06 |
PROMIS-Sleep | |||
POD0 | 65.9 (5.2) | 65.5 (5.5) | 0.07 |
POD1 | 63.5 (5.4) | 62.6 (7.4) | 0.16 |
POD2 | 62.8 (5.5) | 61.1 (8.0) | 0.24* |
POD7 | 60.6 (5.7) | 58.8 (8.2) | 0.26* |
POD30 | 54.3 (7.2) | 54.6 (7.6) | 0.04 |
Pain Catastrophizing | |||
POD0 | 18.4 (11.4) | 20 (10.7) | 0.15 |
POD1 | 9.6 (8.7) | 9.6 (11) | 0.01 |
POD2 | 6 (7.0) | 8.8 (10.8) | 0.32* |
POD7 | 4.8 (5.3) | 5.2 (6.3) | 0.08 |
POD30 | 2.3 (4.9) | 4.2 (8.9) | 0.26* |
Note: *: Absolute mean difference suggesting difference between control and treatment means